Biotech website designBuilt for your next raise, your next partner, and the AI assistants they both ask first.
Crossroad designs and builds websites for biotech and life-sciences companies: scientifically accurate, accessible, and structured so search engines and AI assistants describe your company correctly. One senior team, from first sitemap to post-launch data.
Who reads a biotech website, and what they look for
| Investors | Pipeline, team, and proof of momentum |
|---|---|
| Partners and BD teams | Platform, data, and publications |
| Clinicians and trial sites | Mechanism, trials, and contacts |
| Patients and caregivers | Plain language and a way to take part |
| Candidates | The science, the people, the open roles |
| AI assistants | Structured facts they can quote to all of the above |
The site you built for the seed round is now being read in diligence
Capital is moving in biotech again. Companies funded two to four years ago are reaching new rounds, partnerships, and exits, and the first thing every new reader does is look you up.
Increasingly, they ask an AI assistant instead of opening ten tabs. If your site is thin, out of date, or hard for a machine to parse, the summary they get back is thin too, or describes someone else.
We design for both readers: the person who lands on the page, and the system that reads it on someone's behalf.
What we do
Strategy, design, build, and measurement under one roof, so the people who planned the site are the people who ship it.
Site strategy and messaging
Audiences, sitemap, and the story of your science, pitched for experts and still clear to everyone else.
Brand and visual design
A design system led by our creative director, built around your science instead of stock helixes.
Pipeline, platform, and science pages
The pages investors and partners read most closely, designed to be updated as programs advance.
Search and AI visibility
Structured data, clear entities, and content that answers the questions people and assistants actually ask.
Accessibility built in
WCAG 2.2 AA from the first template, with a published statement. It matters to patients, and it matters before an IPO.
Content migration and measurement
We move everything from your current site, then report on traffic, rankings, and AI referrals after launch.
A project, drawn the way you draw a pipeline
Six phases, with the workstreams that run through them. Search and AI visibility is not a final step; it runs the whole way.
What a relaunch can do in a week
From a recent relaunch for a professional-services client: new design, new platform, same team. Seven days after launch, before the sitemap was submitted to Search Console.
| Change | What moved | Relative size |
|---|---|---|
| +131% | Direct traffic | |
| +41% | Organic search trafficBefore the new sitemap was submitted to Search Console | |
| +400% | Engagement, all channels | |
| +145% | Engagement from direct and from organic visitorsEach channel, measured separately |
The people who pitch are the people who do the work
Two principals, one team. No account layer between you and the people making decisions about your site.
Ben Green
Principal strategist
Search, AI visibility, analytics, and the technical build. Ben specializes in biotech and life sciences and runs every engagement himself.
Amber Love
Creative director
Brand and web design. Amber leads the visual system, the page design, and the details that make a site feel like yours and nobody else's.
Questions people ask first
What makes a biotech website different from other company websites?
A biotech site is read by several expert audiences at once: investors checking the pipeline and team, partners evaluating the platform, clinicians and patients looking for trials, and candidates deciding whether to apply. It has to be scientifically accurate, careful about claims, accessible, and clear enough that an AI assistant can summarize the company correctly.
How much does a biotech website cost?
Every project gets a fixed quote after a discovery call, based on page count, how much content already exists, and how much design and migration work is involved. Focused projects, such as an accessibility remediation or a platform migration, are smaller engagements than a full redesign.
How long does a biotech website take to build?
It depends mostly on page count and how much of the content already exists. After discovery we give you a dated plan with a launch date, and we can sequence the work around a financing, a data readout, or a conference so the site is ready when attention arrives.
Do you work with pre-clinical and early-stage companies?
Yes. Early-stage companies are often where a website matters most, because the site is doing the introducing before the team can. We scope the first version to what you can say today and build it so the pipeline, publications, and news sections grow with you.
How do you make a biotech website visible to AI assistants?
AI assistants answer a question by running many searches and reading what they find. We structure each page to answer the related questions clearly, mark it up with schema that matches the visible content, and make your company's name, people, and programs unambiguous so the assistant describes the right company.
Which CMS do you build biotech websites on?
Usually WordPress on a clean custom foundation, or Webflow, depending on who will maintain the site. If you already have a CMS your team likes, we can work with it and move the content for you.
Talk through your site with the people who would build it
Thirty minutes with Ben. Bring your current site and what is coming up: a raise, a readout, a rebrand. You will leave with a clear view of what the site needs, whether or not we work together.